UK opts out of Unified Patent Court regime
The UK will not be participating in the proposed Unified Patent Court (UPC) regime, despite the country’s ratification of the underlying agreement in April 2018.
The UK’s participation in the UPC, which was put in doubt by its exit from the EU, would have required it to accept being bound by certain EU laws and decisions of the Court of Justice of the European Union (CJEU).
The UK Prime Minister’s Office confirmed the UK’s position concerning the UPC following the publication of its position paper titled The Future Relationship with the EU. Read more on this here.
The commencement of the UPC is currently delayed by a challenge being heard by the German constitutional courts. A decision from the court on whether the UPC is compatible with the German constitution is expected sometime this year.
If the German court finds against the complaint, and Germany decides to ratify the UPC agreement, the UPC may still proceed without the UK. Changes will be required to the current UPC agreement, as under its terms the UK was due to host a section of the central division of the UPC, with responsibility for cases in relation to human necessities (including pharmaceuticals), chemistry and metallurgy. It is likely, however, that one of the other countries that has indicated their intention to participate, such as Italy or the Netherlands, will be prepared to fill this role.
The UK continues to be a contracting state to the European Patent Convention (EPC), which oversees the examination and grant of European Patent applications. The EPC is entirely separate from the European Union and has approximately 40 contracting states. These include all the EU countries but also many non-EU ones.
#cake – a trial by social media
Brexit and intellectual property: Gibraltar, the Isle of Man and
Charlotte looks at where else trade mark and design protection may be required following Brexit.
Diversification of landed estates – a trade mark lawyer’s advice...
Mary looks at the diversification of landed estates and offers her expert advice from a trade mark perspective
Charlotte Duly writes for the Trademark Lawyer Magazine on the legal issues that tribute bands face when selecting a name
Picking a name for a tribute act that makes it clear what they offer whilst avoiding issues with the actual band can be a challenge.
Brexit and Intellectual Property: one month on
Charlotte looks at the impact of Brexit on intellectual property one month on
The Tricky Issue of Joint Authorship in Copyright Works
Where more than one person creates a work, it can be deemed ‘joint authorship’ and each has the same rights as a sole author would.
We’re not all going on a summer holiday – what are the implications for all those unused trade mark registrations?
IP in a Pod: Social Media
What IP issues surround the use and protection of hashtags, memes, GIFs and stickers?
Influencer Agreements: Six points that a business should consider
Due to the commercial power that influencers have over their followers, businesses are increasingly looking to secure their services.
MP’s to Investigate the ‘Economic Impact’ of Music Streaming
The DCMS announced that an inquiry is to be launched into the economics of the music streaming industry.
Q&A examining information notices and the right to manage
Can section 82 of the Commonhold and Leasehold Reform Act 2002 enable an RTM company to serve an information notice on a third party?
Copyright Infringement – Link Available Here
If you reproduce someone else’s work in the form of a link, you could fall foul of copyright law.
Burger King, Stevenage and my FIFA confusion
Trade Mark success for the gymnastics National Governing Body
In a recent case, it was found that UK trade marks for "British Gymnastics, More than a sport" were infringed.
Nick White writes for MCA on the data issues surrounding the rise of popularityy of
The conception of a drinks brand - innovation and IP
Nick White quoted in International Adviser on the scope for musical royalties to be the latest investment craze
David Fyfield writes for Life Sciences Intellectual Property Review on the Supreme Court's ruling in Regeneron Pharmaceuticals Inc v Kymab Ltd
IP in a Pod: Designs and design rights - part 2 (UK rights)
The second part of our two-part episode on designs and design rights.
IP in a Pod: Designs and design rights – part 1 (EU rights)
David, Pete and Rahim discuss registered and unregistered design rights in the European Union.